.png){kind=icon}
.png){kind=icon}
Return
Hyperthyroidism
.png){kind=icon}
OA
AI
DOI：10.1016/S0140-6736(16)00278-6.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the clinical syndrome of excess circulating thyroid hormones, irrespective of the source. The most common cause of hyperthyroidism is Graves' disease, followed by toxic nodular goitre. Other important causes of thyrotoxicosis include thyroiditis, iodine-induced and drug-induced thyroid dysfunction, and factitious ingestion of excess thyroid hormones. Treatment options for Graves' disease include antithyroid drugs, radioactive iodine therapy, and surgery, whereas antithyroid drugs are not generally used long term in toxic nodular goitre, because of the high relapse rate of thyrotoxicosis after discontinuation. beta blockers are used in symptomatic thyrotoxicosis, and might be the only treatment needed for thyrotoxicosis not caused by excessive production and release of the thyroid hormones. Thyroid storm and hyperthyroidism in pregnancy and during the post-partum period are special circumstances that need careful assessment and treatment.
Keywords:
AMERICAN THYROID ASSOCIATION
ANTITHYROID DRUG-TREATMENT
CLINICAL ENDOCRINOLOGISTS GUIDELINES
GRAVES-DISEASE
RADIOIODINE THERAPY
THYROTROPIN-RECEPTOR
SENSITIVE THYROTROPIN
PAINLESS THYROIDITIS
SUBACUTE THYROIDITIS
CONSENSUS STATEMENT
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
88.5
Papers:
5.4W
Citations:
34.8W